Clinical Trials Browser

Phase 2 × Hypersensitivity × Thoracic × Clear all

NCT00116610 2009-01-21

Picoplatin as Second-Line Therapy for Patients With Small Cell Lung Cancer

Phase 2 Completed

Hypersensitivity, Recurrence, Small Cell Lung Carcinoma